(Q77386827)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

A Alexopoulou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A M Owsianka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

G Kafiri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S P Dourakis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

W F Carman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S J Hadziyannis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

345-351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Emergence and selection of HBV variants in an anti-HBe positive patient persistently infected with quasi-species

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Factors predictive of response to interferon therapy in children with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Persistence of "wild-type" and "e-minus" hepatitis B virus infection in chronic healthy HBsAg/anti-HBe positive carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Long-term follow-up of anti-HBe-positive chronic active hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

What technique should be used for routine detection and quantification of HBV DNA in clinical samples?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Precore mutations and core clustering mutations in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980050-0

7 January 2021

10.1016/S0168-8278(98)80050-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9764979%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference